Myelodysplastic Syndrome (MDS)
Showing NaN - NaN of 9
Myelodysplastic Syndrome (MDS) Trial in Worldwide (Venetoclax, Azacitidine, Placebo)
Active, not recruiting
- Myelodysplastic Syndrome (MDS)
- Venetoclax
- +2 more
-
Fullerton, California
- +219 more
Aug 24, 2022
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Worldwide (Lemzoparlimab, Azacitidine, Venetoclax)
Recruiting
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
- Lemzoparlimab
- +2 more
-
Birmingham, Alabama
- +35 more
Aug 19, 2022
Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®
Active, not recruiting
- Hematological Malignancies
- +6 more
- NiCord® (omidubicel)
- Cord Blood Unit
-
Los Angeles, California
- +51 more
Jan 7, 2021
Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML) Trial in Worldwide (NiCord®)
Completed
- Hematological Malignancies
- +3 more
-
Los Angeles, California
- +14 more
Oct 1, 2020
For Donors, Related Donors Giving Peripheral Blood Stem Cells (PBSC) to a Sibling, For Recipients Trial in United States
Terminated
- For Donors
- +9 more
- CDX-301
- CDX-301 and plerixafor
-
Los Angeles, California
- +7 more
Apr 6, 2017
Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) Trial in Worldwide (birinapant, Azacitidine, Placebo)
Terminated
- Myelodysplastic Syndrome (MDS)
- Chronic Myelomonocytic Leukemia (CMML)
- birinapant
- +2 more
-
Glendale, Arizona
- +75 more
Oct 18, 2016
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in United States (Treosulfan)
Completed
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
-
Birmingham, Alabama
- +22 more
Oct 10, 2016
Myelodysplastic Syndrome (MDS) Trial in United States (Ezatiostat Hydrochloride)
Completed
- Myelodysplastic Syndrome (MDS)
- Ezatiostat Hydrochloride
-
Tucson, Arizona
- +35 more
Oct 10, 2011